Northwestern University Feinberg School of Medicine's Division of Rheumatology has faculty members involved in all phases of the cycle of medical research; from the lab bench to the bedside and back. Medical research begins in a laboratory, with studies that are concerned with the fundamental biologic functions of the body's tissues and the ways in which those functions are disrupted in disease. The knowledge generated in the laboratory is then validated in the real world, putting it to practical use and pointing the way towards actual changes in patient care. Finally, analysis of the outcomes of current and new therapies allow us to identify areas where interventions are working or not working, and is the way by which new medicines and other new treatments come into widespread use in actual medical practice.
The Division of Rheumatology receives funding from numerous federally-sponsored grants, including a T-32 training grant and the P60 Multidisciplinary Clinical Research Center. We also participate in clinical trials, which give our patients the opportunity to be among the first to receive new medications or other new forms of treatment.
Contact Us regarding medical student, resident, or other research opportunities within the division.
Learn more about our faculty's research via the links below.
Research Centers and Programs
Learn more about faculty research in Rheumatology via the following program and center websites.
- Lupus Program at Northwestern University (Systemic lupus erythematosus)
Rosalind Ramsey-Goldman, MD, DrPh, Program Director
- Scleroderma Program
John Varga, MD, Program Director
- Multidisciplinary Clinical Research Center
Leena Sharma, MD, Center Director
- RhEumatoid Arthritis SynOvial tissue Network
Harris Perlman, PhD, Director
Learn more about the lab work within our division.
The Perlman Lab centers on rheumatic disease, particularly the impact that macrophages play in pathogenesis of rheumatic disease.
The Pope Lab studies the biology of macrophages in the pathogenesis of rheumatoid arthritis (RA). These studies are directed at defining the mechanisms that promote resistance to apoptosis or programmed cell death and the role of endogenous Toll Like Receptor (TLR) ligands in the pathogensis of RA.
Research in the Stehlik laboratory focuses on the inflammatory host response during infectious and inflammatory disease with a particular focus on regulation of inflammasomes in phagocytic cells.
Research in our laboratory focuses on the mechanisms of fibrosis and inflammation/autoimmunity in human diseases.